XML 40 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Description of Business, Basis of Consolidation and Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2015
Summary of Business Sales and Gross Profit Information

Based on similar economic and operational characteristics, the Company’s business is aggregated into one reportable segment. Selective enterprise information is as follows:

 

     2015      2014      2013  

Net sales:

        

Insecticides

   $ 117,180       $ 135,705       $ 193,623   

Herbicides/soil fumigants/fungicides

     111,897         101,785         121,042   

Other, including plant growth regulators

     29,013         30,220         31,849   
  

 

 

    

 

 

    

 

 

 

Total crop

     258,090         267,710         346,514   

Non-crop

     31,292         30,924         34,507   
  

 

 

    

 

 

    

 

 

 
   $ 289,382       $ 298,634       $ 381,021   
  

 

 

    

 

 

    

 

 

 

Gross profit:

        

Crop

   $ 97,198       $ 101,633       $ 155,275   

Non-crop

     14,704         12,863         16,072   
  

 

 

    

 

 

    

 

 

 
   $ 111,902       $ 114,496       $ 171,347   
  

 

 

    

 

 

    

 

 

 
Summary of Operating Expense

Operating expenses include cost centers for Selling, General and Administrative, Research, Product Development, and Regulatory, and finally, Freight, Delivery and Warehousing.

 

     2015      2014      2013  

Selling

   $ 27,360       $ 31,593       $ 32,929   

General and administrative

     28,516         27,057         33,536   

Research, product development and regulatory

     18,808         21,206         21,644   

Freight, delivery and warehousing

     25,694         27,930         27,503   
  

 

 

    

 

 

    

 

 

 
   $ 100,378       $ 107,786       $ 115,612
  

 

 

    

 

 

    

 

 

 
Components of Inventories

The components of inventories consist of the following:

 

     2015      2014  

Finished products

   $ 120,456       $ 142,853   

Raw materials

     16,021         22,778   
  

 

 

    

 

 

 
   $ 136,477       $ 165,631   
  

 

 

    

 

 

 
Impact of Derivatives on Statement of Operations

The following tables illustrate the impact of derivatives on the Company’s statement of operations for the year ended December 31, 2015 and 2014.

 

The Effect of Derivative Instruments on the Statement of Financial Performance

For the Year Ended December 31

 

Derivatives in ASC 815 Cash Flow

Hedging Relationships

   Amount of Gain or
(Loss) Recognized in
OCI on Derivative
(Effective Portion)
    Location of Gain or
(Loss) Reclassified
from Accumulated
OCI into Income

(Effective Portion)
     Amount of Gain or
(Loss) Reclassified
from Accumulated
OCI into Income
(Effective Portion)
    Location of Gain or
(Loss) Recognized in
Income on Derivative

(Ineffective Portion)
     Amount of Gain or
(Loss) Recognized
in Income on
Derivative
(Ineffective Portion)
 
   2015      2014        2015     2014        2015     2014  

Interest rate contracts

   $ 0       $ (30     Interest expense       $ (0   $ (594     Interest expense       $ (0   $ (3
  

 

 

    

 

 

      

 

 

   

 

 

      

 

 

   

 

 

 

Total

   $ 0       $ (30      $ (0   $ (594      $ (0   $ (3
  

 

 

    

 

 

      

 

 

   

 

 

      

 

 

   

 

 

 
Components of Basic and Diluted Earnings per Share

The components of basic and diluted earnings per share were as follows:

 

     2015      2014      2013  

Numerator:

        

Net income attributable to American Vanguard

   $ 6,591       $ 4,841       $ 34,449   
  

 

 

    

 

 

    

 

 

 

Denominator:

        

Weighted average shares outstanding—basic

     28,673         28,436         28,301   

Dilutive effect of stock options and grants

     564         476         598   
  

 

 

    

 

 

    

 

 

 
     29,237         28,912         28,899   
  

 

 

    

 

 

    

 

 

 
Unamortized Stock Based Compensation Expenses

The below tables illustrate the Company’s stock based compensation, unamortized stock-based compensation, and remaining weighted average period for the year ended December 31, 2015, 2014 and 2013. This projected expense will change if any stock options and restricted stock are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures.

 

    
Stock-Based
Compensation
     Unamortized
Stock-Based
Compensation
     Remaining
Weighted
Average
Period (years)
 

December 31, 2015

        

Incentive Stock Options

   $ 431       $ 887         2.0   

Performance Based Options

     149         331         2.0   

Restricted Stock

     2,972         2,153         1.3   

Performance Based Restricted Stock

     329         583         1.5   
  

 

 

    

 

 

    

Total

   $ 3,881       $ 3,954      
  

 

 

    

 

 

    

December 31, 2014

        

Incentive Stock Options

   $ 22       $ 1,457         3.0   

Performance Based Options

     —           551         3.0   

Restricted Stock

     3,963         4,829         1.8   

Performance Based Restricted Stock

     168         1,249         2.1   
  

 

 

    

 

 

    

Total

   $ 4,153       $ 8,086      
  

 

 

    

 

 

    

December 31, 2013

        

Incentive Stock Options

   $ 764       $ 21         0.5   

Restricted Stock

     2,965         5,435         1.9   

Performance Based Restricted Stock

     90         564         2.4   
  

 

 

    

 

 

    

Total

   $ 3,819       $ 6,020      
  

 

 

    

 

 

    
Summary of Value Option Grants Using Weighted Average Assumptions

The Company uses the Black-Scholes option-pricing model (“Black-Scholes model”) to value option grants using the following weighted average assumptions:

 

     2014  

Risk free interest rate

     2.0

Dividend yield

     0.9

Volatility factor

     48.9

Weighted average life (years)

     6.5 years